This trial will test whether UVA1 phototherapy is an effective and safe treatment for vitiligo.
1 Primary · 1 Secondary · Reporting Duration: assessments at 2, 4, 6, and 8 weeks during treatment then at 4, 8, and 12 weeks post treatment
Active Control
16 Total Participants · 2 Treatment Groups
Primary Treatment: UVA1 · No Placebo Group · Phase 2
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: